Feasibility Study on LITT for Newly Diagnosed Glioblastoma
Status:
Terminated
Trial end date:
2018-09-14
Target enrollment:
Participant gender:
Summary
Multicenter, open-label, prospective designed study to characterize the performance of brain
laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in
combination with standard of care radiation therapy and temozolomide for the treatment of
newly diagnosed glioblastomas (GBM).